Skip to main
INMD
INMD logo

Inmode Ltd (INMD) Stock Forecast & Price Target

Inmode Ltd (INMD) Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 0%
Buy 25%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

InMode Ltd demonstrated robust sales activity with the sale of 971 systems in the second quarter of 2025, contributing to a global installed base of approximately 28,855 units, marking a 3.4% increase from the previous quarter. The company's operating margin improved to 27.5%, surpassing estimated expectations and reflecting a year-over-year increase of 40 basis points. Additionally, the domestic sales growth of 9% in the second quarter, an improvement from a 7% decline in the first quarter, underscores the rising consumer and physician interest in the expanding aesthetics market.

Bears say

InMode Ltd is facing a challenging financial outlook as its gross margins are expected to contract, despite currently remaining among the highest in the med tech sector. The company's projected revenue growth is anticipated to slow, with a compound annual growth rate (CAGR) of less than 5% due to underwhelming performance from existing products and sluggish adoption of new ones. Additionally, while there has been an improvement in operating margins, the overall trend indicates that earnings per share (EPS) growth may lag behind revenue growth, signaling potential profitability concerns.

Inmode Ltd (INMD) has been analyzed by 4 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 25% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inmode Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inmode Ltd (INMD) Forecast

Analysts have given Inmode Ltd (INMD) a Hold based on their latest research and market trends.

According to 4 analysts, Inmode Ltd (INMD) has a Hold consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inmode Ltd (INMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.